Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
advances in neurology
agitation
AMPA receptor antibodies
amphiphysin antibodies
anti IgLON5
ataxia
ataxia, cerebellar
ataxia, truncal
ataxic gait
autoantibodies
autoimmune basal ganglia encephalitis
autoimmune disease
autoimmune encephalopathy
autonomic dysfunction
basal ganglia, lesion of
basal ganglia, lesion, bilateral
behavioral disorder
behavioral disorder, acute
carcinoma
catatonia
cerebellar degeneration
cerebellitis, autoimmune
cerebral cortex
children
chorea
choreoathetosis
cognition
collapsin response mediator protein 5 IgG
complications
confusion
constipation
dementia
diagnostic criteria
diarrhea
differential diagnosis
diplopia
DPPX
DPPX, antibodies
DPPX, antibodies, encephalitis
dysarthria
dysdiadochokinesia
dyskinesia
dyskinesia, facial
dysphagia
dystonia
electroencephalogram, abnormalities of
encephalitis
encephalitis, autoimmune
encephalitis, etiology
encephalitis, paraneoplastic
encephalitis, viral
eye movement, disorders of
faciobrachial dystonic seizure
fever
gait disorder
gamma amino butyric acid receptor antibody
gastrointestinal disease, neurologic complications
gender
glycine receptor antibodies
hallucination
headache
herpes simplex encephalitis
hyperekplexia
hyperesthesia
hypersomnia
hyponatremia
immunologic disease
immunotherapy
insomnia
intellectual deficit
intellectual deterioration
leucine rich glioma inactivated 1 antibodies
level of consciousness, decreased
limbic encephalitis
memory
memory, defect of recent
memory, impairment of
mental status, abnormal
mesial temporal lobe
monoclonal antibodies
movement disorder
movement disorder, extrapyramidal
MRI
MRI, abnormal
MRI, contrast enhanced
MRI, FLAIR
MRI, negative
myelitis, transverse, recurrent
myoclonus
neurexin-3 alpha antibodies
neurologic disease, diagnoses of
neuronal cell surface antigen
NMDA antagonists
nystagmus
personality change
pleocytosis of cerebrospinal fluid
precipitating factors
prognosis
progressive neurologic disorder
psychiatric problems in neurologic disorders
psychosis
recurrent
remote effect of cancer on the nervous system
review article
rituximab
screening
seizure
seizure, adult onset
seizure, unknown origin
serologic testing
serologic testing, false negative
sleep pathology and physiology
speech disorder
striatal encephalitis
striatum, lesion of
striatum, lesion of, bilateral
temporal lobe, lesion
temporal lobe, lesion, bilateral
teratoma
teratoma, ovarian
thymoma
titubation
treatment of neurologic disorder
tremor
walking, difficulty with
weight loss
white matter disease
white matter disease, subcortical
wide based gait
workup
Showing articles 450 to 500 of 1117 << Previous Next >>

Anti-NMDA Receptor Encephalitis Causing Prolonged Nonconvulsive Status Epilepticus
Neurol 75:1480-1482, Johnson,N.,et al, 2010

Non-Paraneoplastic Limbic Encephalitis Characterized by Mesio-Temporal Seizures and Extratemporal Lesions: A Case Report
Seizure 19:446-449, Cianci,V.,et al, 2010

Anti-N-Methyl-d-Aspartate Receptor Encephalitis: Characteristic Behavioral and Movement Disorder
Arch Neurol 67:250-251, Ferioli,S.,et al, 2010

Severe Cutaneous Candida Infection During Natalizumab Therapy in Multiple Sclerosis
Neurol 74:521-523, Gutwinski,S.,et al, 2010

Cancer-Associated Myositis and Anti-p155 Autoantibody in a Series of 85 Patients with Idiopathic Inflammatory Myopathy
Medicine 89:47-52, Trallero-Araguas,E.,et al, 2010

Reversible Paraneoplpastic Limbic Encephalitis Associated with Antibodies to the AMPA Receptor
Neurol 74:265-267, Bataller,L.,et al, 2010

Long-Term Survival with Favorable Cognitive Outcome After Chemotherapy in Primary Central Nervous System Lymphoma
Ann Neurol 67:182-189, Juergens,A.,et al, 2010

Neurosacrcoidosis: Presentations and Management
Neurologist 16:2-15, Terushkin,V.,et al, 2010

Opsoclonus-Myoclonus Syndrome in Anti-N-Methyl-D-Aspartate Receptor Encephalitis
Arch Neurol 67:118-121, Kurian,M.,et al, 2010

Positron Emission Tomography-Computed Tomography in Paraneoplastic Neurologic Disorders: Systematic Analysis and Review
Arch Neurol 67:322-329, McKeon,A.,et al, 2010

The Expanding Clinical Profile of Anti-AMPA Receptor Encephalitis
Neurol 74:857-859, Graus,F.,et al, 2010

Infectious and Non-Infectious Neurologic Complications in Heart Transplant Recipients
Medicine 89:166-175, Mu�oz,P., et al, 2010

Antibodies to Glutamic Acid Decarboxylase Define a Form of Limbic Encephalitis
Ann Neurol 67:470-478, Malter,M.P., et al, 2010

Response to Immunotherapy in a 20-Month-Old Boy With Anti-NMDA Receptor Encephalitis
Neurol 74:1550-1551, Wong-Kisiel,L.C., et al, 2010

NMDA Receptor Encephalitis Mimicking Seronegative Neuromyelitis Optica
Neurol 74:1473-1475, Kruer,M.C., et al, 2010

Posterior Reversible Encephalopathy Syndrome After Rituximab Infusion in Neuromyelitis Optica
Neurol 74:1471-1473, S�nchez-Carteyron,A., et al, 2010

Treatment of Refractory Neurosarcoidosis with Infliximab
JNNP 81:241-246, Santos,E., et al, 2010

Natalizumab and Progressive Multifocal Leukoencephalopathy: What are the Causal Factors and Can It be Avoided?
Arch Neurol 67:923-930, Warnke,C., et al, 2010

A Case of Neurosarcoidosis Successfully Treated with Rituximab
Neurol 75:568-570, Bomprezzi,R., et al, 2010

Clinical Reasoning: A 9-year-old Girl With Seizures and Encephalopathy
Neurol 74:e97-e100, Nguyen,T.P. &El-Hakam,L.M., 2010

JC Virus Infection of the Brain
AJNR 31:1564-1576, Bag,A.K.,et al, 2010

An Effective Immunotherapy Regimen for VGKC Antibody-Positive Limbic Encephalitis
JNNP 81:1167-1169, Wong,S.H.,et al, 2010

Challenge of the Unknown: A Systematic Review of Acute Encephalitis in Non-Outbreak Situations
Neurol 75:924-932, Granerod,J. et al, 2010

Best Practice Recommendations for the Selection and Management of Patients with Multiple Sclerosis Receiving Natalizumab Therapy
Mutliple Sclerosis 15:S26-S36, Coyle,P.K.,et al, 2009

High-Dose Cytarabine Plus High-Dose Methotrexate Versus High-Dose Methotrexate Alone in Patients with Primary CNS Lymphoma: A Randomised Phase 2 Trial
Lancet 374:1512-1520, 1477, Ferreri,A.,et al, 2009

Acute Limbic Encephalitis and Glutamic Acid Decarboxylase Antibodies:A Reality?
J Neurosci 287:69-71, Blanc,F.,et al, 2009

Limbic Encephalitis Associated with Anti-GAD Antibody and Common Variable Immune Deficiency
Dev Med Child Neurol 51:563-567, Akman,C.I.,et al, 2009

Voltage-gated Potassium Channel-associated Limbic Encepahlitis in the West of Scotland:Case Reports and Literature Review
Scott Med J 54:27-31, Reid,J.M.,et al, 2009

Treatment of CNS Sarcoidosis with Infliximab and Mycophenolate Mofetil
Neurol 72:337-340, Morovan,M. &Segal,B.M., 2009

Immunologic, Clinical, and Radiologic Status 14 Months After Cessation of Natalizumab Therapy
Neurol 72:396-401,392, Stuve,O.,et al, 2009

Posterior Reversible Encephalopathy Syndrome in Neuromyelitis Optica Spectrum Disorders
Neurol 72:712-717, Maga�a,S.M.,et al, 2009

Multiple Sclerosis Therapeutics: Unexpected Outcomes Clouding Undisputed Successes
Neurol 72:1008-1015, Wiendl,H. &Hohlfeld,R., 2009

Opportunistic Infections and Other Risks with Newer Multiple Sclerosis Therapies
Ann Neurol 65:367-377, Berger,J.R. &Houff,S., 2009

In Vivo Mapping of Amyloid Toxicity in Alzheimer Disease
Neurol 72:1504-1511, Frisoni,B.G.,et al, 2009

Human Natural Autoantibodies in the Treatment of Neurologic Disease
Neurol 72:1269-1276, Rodriguez,M.,et al, 2009

Diagnosis and New Treatment in Muscle Channelopathies
JNNP 80:360-365, Meola,G.,et al, 2009

Recurrent Pericarditis Due to Natalizumab Treatment
Neurol 72:1616-1617, Cohen,M.,et al, 2009

Progressive Multifocal Leukoencephalopathy and Relapsing-Remitting Multiple Sclerosis: A Comparative Study
Arch Neurol 66:593-599, Boster,A.,et al, 2009

Long-Term Effects of the Concomitant Use of Memantine with Cholinesterase Inhibition in Alzheimer Disease
JNNP 80:600-607, Lopez,O.L.,et al, 2009

Hearing Improvement After Bevacizumab in Patients with Neurofibromatosis Type 2
NEJM 361:358-367, Plotkin,S.R.,et al, 2009

Risk of Dementia and AD with Prior Exposure to NSAIDs in an Elderly Community-Based Cohort
Neurol 72:1899-1905,1884, Breitner,J.C.S.,et al, 2009

Anti-N-Methyl-D-Aspartate Receptor (NHMDAR) Encephalitis in Children and Adolescents
Ann Neurol 66:11-18,1, Florance,N.R.,et al, 2009

Primary Central Nervous System Lymphoma in a Patient Treated with Natalizumab
Ann Neurol 66:403-406, 261, 262, Schweikert,A.,et al, 2009

Natalizumab and Central Nervous System Lymphoma: No Clear Association
Ann Neurol 66:261-262, Bozic,C.,et al, 2009

Progressive Multifocal Leukoencephalopathy After Natalizumab Monotherapy
NEJM 361:1081-1087, Linda,H.,et al, 2009

Treatment of Progressive Multifocal Leukoencephalopathy Associated with Natalizumab
NEJM 361:1075-1080, Wenning,W.,et al, 2009

Limbic Encephalitis Associated With Antibodies to the NMDA Receptor in Hodgkin Lymphoma
Neurol 73:2039-2040, Zanid,M.S.,et al, 2009

N-Methyl-D-Aspartate Receptor Antibodies in Pediatric Dyskinetic Encephalitis Lethargica
Ann Neurol 66:704-709, Dale,R.,et al, 2009

Paraneoplastic Syndromes Affecting Brain and Cranial Nerves
UpToDate May 2009, Dalmau,J. &Rosenfeld,M., 2009

Multifocal Paraneoplastic Cortical Encephalitis Associated With Myasthenia Gravis and Thymoma
Arch Neurol 66:1407-1409, Hammoud,K.,et al, 2009



Showing articles 450 to 500 of 1117 << Previous Next >>